Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.

PLoS One · 2015 · PMC4471111 · PMID 26083256

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

When EGFR expression was evaluated at the same time-points, it was shown that more patients harbored EGFR-positive CTCs on disease progression compared to the pre-treatment sample and this difference showed a trend for statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.